OICR-10268

N/A

Report date: 2025/01/26 16:03:05
NME

Base Information

Drug NameOICR-10268
Drug Alias NameBCL6 inhibitor (Ontario Institute for Cancer Research/The University Health Network)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionB-cell lymphoma 6 protein inhibitors
TargetsB-cell lymphoma 6 protein
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOntario Institute For Cancer Research
China Registration ClassN/A

Develop Information

Active CompaniesOntario Institute For Cancer ResearchUniversity Health Network (Uhn)
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A